Month: December 2016

Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy

Collaboration between Stem Cell Clinician, Neurologist, and Cell Therapy Developer Results in Novel Regenerative Approach to Stroke PHOENIX and SAN DIEGO, Dec. 13, 2016 /PRNewswire/ — Creative Medical Technology Holdings (the “Company”) (OTCQB:CELZ) announced today filing of US patent application #62/400557 entitled “Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived Thereof.” The …

Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy Read More »

Creative Medical Technology Holdings Recruits Internationally Renowned Neurologist to Assist in Clinical Development of AmnioStem Stem Cell Therapy for Stroke

Clinical Stage Stem Cell Therapeutics Company Aims to Develop “Universal Donor” Stem Cell “Drug” for Stroke Patients PHOENIX and SAN DIEGO, Dec. 6, 2016 /PRNewswire/ — Creative Medical Technology Holdings (OTCQB:CELZ) announced the appointment of Santosh Kesari, MD, PhD, FANA, FAAN to the Company’s Scientific Advisory Board. Dr. Kesari will leverage his experience in neurology and clinical trials to assist the Company’s …

Creative Medical Technology Holdings Recruits Internationally Renowned Neurologist to Assist in Clinical Development of AmnioStem Stem Cell Therapy for Stroke Read More »